Hakan Drevin

Title: Hakan Drevin: Innovator in HIV Research

Introduction

Hakan Drevin is a notable inventor based in Uppsala, Sweden. He has made significant contributions to the field of HIV research, holding a total of 3 patents. His work focuses on innovative diagnostic methods and recombinant proteins that aid in the understanding and treatment of HIV.

Latest Patents

One of Hakan Drevin's latest patents is titled "HIV antibody assays comprising p24-gp41 chimeric antigens." This invention relates to a DNA segment encoding a recombinant HIV p24 protein or an HIV p24-gp41 fusion protein. It also includes a recombinant DNA (rDNA) molecule capable of expressing either protein. The patent describes cells transformed with the rDNA, methods for producing the fusion protein, and diagnostic methods and systems utilizing the fusion protein.

Career Highlights

Throughout his career, Hakan Drevin has worked with prominent companies in the biotechnology sector. Notably, he has been associated with Pharmacia Genetic Engineering, Inc. and Pharmacia AB. His experience in these organizations has contributed to his expertise in genetic engineering and HIV research.

Collaborations

Hakan Drevin has collaborated with several professionals in his field, including Torsten B Helting and Michael F Nunn. These collaborations have likely enhanced his research and development efforts in HIV diagnostics and therapeutics.

Conclusion

Hakan Drevin is a distinguished inventor whose work in HIV research has led to valuable patents and advancements in diagnostic methods. His contributions continue to impact the field positively.